Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research

References

• Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.
   PubMed Web of Science ®Google Scholar
• Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123:612–624.
   PubMed Web of Science ®Google Scholar
• Mahmoud AN, Mentias A, Elgendy AY, et al. Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open. 2018;8:e020498.
   PubMed Web of Science ®Google Scholar
• Xu Z, Li Y, Tang S, et al. Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies. Thromb Res. 2015 Jul;136(1):52–60.
   PubMed Web of Science ®Google Scholar
• Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330:63.
   PubMed Web of Science ®Google Scholar
• Champaloux SW, Tepper NK, Monsour M, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216:489.e1-489.e7.
   PubMed Web of Science ®Google Scholar
• Sacco S, Merki-Feld GS, Ægidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct;18:108.
   PubMed Web of Science ®Google Scholar
• Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA. 2000 Jul;284:72–78.
   PubMed Web of Science ®Google Scholar
• Sheikh HU, Pavlovic J, Loder E, et al. Risk of stroke associated with use of estrogen containing contraceptives in women with migraine: a systematic review. Headache. 2018 Jan;58:5–21.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [cited 2019 Jun 14]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Tzourio C, Tehindrazanarivelo A, Iglésias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ. 1995;310:830–833.
   PubMed Web of Science ®Google Scholar
• Schwartz SM, Petitti DB, Siscovick DS, et al. Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke. 1998;29:2277–2284.
   PubMed Web of Science ®Google Scholar
• Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999 Jan;318:13–18.
   PubMed Web of Science ®Google Scholar
• Fletcher J. What is heterogeneity and is it important? BMJ. 2007 Jan;334:94–96.
   PubMed Web of Science ®Google Scholar
• Donaghy M, Chang CL, Poulter N, et al. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747–750.
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296:283–291.
   PubMed Web of Science ®Google Scholar
• Bousser MG, Conard J, Kittner S, et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia. 2000;20:155–156.
   PubMed Web of Science ®Google Scholar
• Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet. 1996 Jun;347:1503–1506.
   PubMed Web of Science ®Google Scholar
• MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke. 2007;38:2438–2445.
   PubMed Web of Science ®Google Scholar
• Sacco S, Pistoia F, Degan D, et al. Conventional vascular risk factors: their role in the association between migraine and cardiovascular diseases. Cephalalgia. 2015;35:146–164.
   PubMed Web of Science ®Google Scholar
• Sacco S, Kurth T. Migraine and the risk for stroke and cardiovascular disease. Curr Cardiol Rep. 2014 Sep;16:524.
   PubMed Web of Science ®Google Scholar
• Sacco S, Cerone D, Carolei A. Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain. 2008 Aug;9:237–248.
   PubMed Web of Science ®Google Scholar
• Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 2012 Jul;32:785–795.
   PubMed Web of Science ®Google Scholar
• Sacco S, Ricci S, Degan D, et al. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–189.
   PubMed Web of Science ®Google Scholar
• Tietjen GE, Collins SA. Hypercoagulability and migraine. Headache. 2018 Jan;58:173–183.
   PubMedGoogle Scholar
• Ailani J. Migraine and patent foramen ovale. Curr Neurol Neurosci Rep. 2014 Feb;14:426.
   PubMed Web of Science ®Google Scholar
• Davis D, Gregson J, Willeit P, et al. Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology. 2013;40:56–67.
   PubMed Web of Science ®Google Scholar
• Hamedani AG, Rose KM, Peterlin BL, et al. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology. 2013;81:1308–1313.
   PubMed Web of Science ®Google Scholar
• Colombo B, Dalla Libera D, Comi G. Brain white matter lesions in migraine: what’s the meaning? Neurol Sci. 2011 May;32(Suppl 1):S37–40.
   PubMedGoogle Scholar
• Sacco S, Ripa P, Grassi D, et al. Peripheral vascular dysfunction in migraine: a review. J Headache Pain. 2013;14:80.
   PubMed Web of Science ®Google Scholar
• Bousser MG. Estrogens, migraine, and stroke. Stroke. 2004 Nov;35(11 Suppl 1):2652–2656.
   PubMedGoogle Scholar